Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a ...

Bio-Techne rose 4% on a report that activist investor Ananym Capital Management has accumulated a stake in the maker of ...

Techne’s stock price fell to $51.95. Shareholders have lost 13.8% of their capital, which is disappointing considering the ...

Bio-Techne (TECH) has drawn fresh investor interest after teaming up with Refeyn on a four hour integrated workflow that links charge heterogeneity, molecular weight, and aggregation in bispecific ...

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

TECH is set to post Q2 results on Feb. 4, with EPS expected at 43 cents and revenues seen at $292 million. TECH faces Q2 uncertainty from tariffs and NIH budget cuts, with cell therapy timing weighing ...

The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...

Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...

MINNEAPOLIS, Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media ...